IAIM
RPRX icon

International Assets Investment Management’s Royalty Pharma RPRX Stock Holding History

International Assets Investment Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,163
Closed -$41.9K – 839
2023
Q1 		$41.9K Buy
+1,163
New +$43.1K 0.01% 703
2021
Q2 		– Sell
-295
Closed -$13K – 1600
2021
Q1 		$13K Buy
295
+216
+273% +$10.2K ﹤0.01% 1472
2020
Q4 		$4K Buy
+79
New +$3.35K ﹤0.01% 1725

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

International Assets Investment Management's RPRX Position: Q2 2023 in Review

International Assets Investment Management sold out of Royalty Pharma (RPRX) in Q2 2023, closing a stake of 1,163 shares — an estimated $41.9K sold.

International Assets Investment Management first reported a position in RPRX in Q4 2020 and held it in 3 quarters. The position peaked at $41.9K in Q1 2023. 326 funds tracked by Wall St. Rank hold RPRX as of Q2 2023.

  • International Assets Investment Management reported no remaining Royalty Pharma position as of Q2 2023 after selling out during the quarter.
  • International Assets Investment Management sold 1,163 Royalty Pharma shares in Q2 2023, an estimated $41.9K.
  • International Assets Investment Management first reported a position in Royalty Pharma in Q4 2020 and held it in 3 quarters.
  • International Assets Investment Management's Royalty Pharma position peaked at $41.9K in Q1 2023.
  • 326 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2023.

Based on International Assets Investment Management's 13F filing for Q2 2023, filed 20 Jul 2023.